Short answer
MeiraGTx Holdings plc (MGTX) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results cover the quarter ended June 30, 2026.
MeiraGTx Holdings plc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results cover the quarter ended June 30, 2026
- Press release issued August 13, 2026 and furnished as Exhibit 99.1
- Results are furnished, not filed under Exchange Act Section 18 liability provisions
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $321.4M and net income $160.7M, driven largely by nonrecurring related-party license and service revenue
- R&D expense rose to $57.8M from $33.5M, reflecting bota-vec reacquisition and higher AAV2-hAQP1 clinical manufacturing and trial spending
- Bota-vec acquired for $25M, with global regulatory filings targeted in 2026 and potential commercial launch in 2027
- Oberland investment provides $135M initially and up to $400M total, including up to $375M nondilutive royalty-backed capital
- AQUAx2 enrollment completed; 12-month pivotal readout targeted Q2 2027, supporting potential AAV2-hAQP1 BLA filing and 2028 U.S. launch
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MeiraGTx Holdings plc 8-K filings
Get the next MGTX 8-K as it lands
Follow MGTX for push alerts, or ask the research agent what this filing means.